Monte Rosa Therapeutics Inc
(GLUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | RAPP | BHVN | ||
| Company | Monte Rosa Therapeutics Inc | Rapport Therapeutics Inc | Biohaven Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 19.27 | 26.44 | 11.32 | ||
| High | 20.29 | 27.60 | 11.78 | ||
| Low | 19.09 | 26.16 | 11.02 | ||
| Latest | 19.55 | 27.09 | 11.60 | ||
| Change | +0.65 | +1.54 | +0.84 | ||
| % Change | +3.44% | +6.03% | +7.81% | ||
| Volume | 1,358,800 | 301,700 | 2,443,000 | ||
| 20-Day Average Volume | 1,482,000 | 338,145 | 2,873,220 | ||
| Previous Close | 18.90 | 25.55 | 10.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.33 | 26.96 | 12.08 | ||
| 20-Day Raw Stochastic | 10.72% | 39.83% | 34.18% | ||
| 20-Day Relative Strength | 49.20 | 48.66 | 49.59 | ||
| Weighted Alpha | +125.09 | +14.85 | -24.78 | ||
| Today's Opinion | 80% Buy | 24% Buy | 64% Sell | ||
| Previous Opinion | 64% Buy | 8% Buy | 80% Sell | ||
| Last Month's Opinion | 100% Buy | 96% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.73% since 01/30/26 | +1.80% since 01/30/26 | -1.94% since 01/30/26 | ||
| Low | 18.85 on 02/05/26 | 25.21 on 02/05/26 | 10.61 on 02/05/26 | ||
| High | 21.69 on 02/03/26 | 28.59 on 02/03/26 | 12.11 on 02/02/26 | ||
| 1-Month | |||||
| %Chg | +22.11% since 01/06/26 | -2.06% since 01/06/26 | +20.58% since 01/06/26 | ||
| Low | 18.85 on 02/05/26 | 25.21 on 02/05/26 | 9.68 on 01/07/26 | ||
| High | 25.77 on 01/08/26 | 30.79 on 01/07/26 | 14.01 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +50.27% since 11/06/25 | +6.82% since 11/06/25 | +35.99% since 11/06/25 | ||
| Low | 11.90 on 11/07/25 | 23.75 on 11/17/25 | 7.48 on 11/11/25 | ||
| High | 25.77 on 01/08/26 | 32.36 on 12/23/25 | 14.01 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | +348.91% since 08/06/25 | +85.42% since 08/06/25 | -22.97% since 08/06/25 | ||
| Low | 4.12 on 08/08/25 | 13.62 on 08/07/25 | 7.48 on 11/11/25 | ||
| High | 25.77 on 01/08/26 | 42.27 on 09/08/25 | 18.57 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,273,057 | 1,291,136 | 1,227,918 | ||
| Shares Outstanding, K | 65,118 | 47,661 | 105,855 | ||
| Annual Sales | 75,620,000 | 0 | 0 | ||
| Annual Net Income | -72,700,000 | -78,310,000 | -846,420,000 | ||
| Last Quarter Sales | 12,770,000 | 0 | 0 | ||
| Last Quarter Net Income | -27,080,000 | -26,930,000 | -173,440,000 | ||
| 60-Month Beta | 1.61 | 1.63 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 11/06/25 | -0.71 on 11/06/25 | -1.64 on 11/10/25 | ||
| Latest Earnings Date | 03/19/26 | 03/10/26 | 03/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 59.06 | 0.00 | 0.00 | ||